House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Pain medicine

Infection control for regional anaesthesia and pain medicine

ASRA Pain Medicine · 2025 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

These ASRA recommendation sheets cover infection prevention and management before, during and after regional-anaesthesia and pain procedures. Recommendations are tied to procedure classes in the full guideline; a grade does not remove those class restrictions. The summary retains selected actionable recommendations from the sheets, not the complete corrected journal guideline.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Preparation and prophylaxis

  • For class C and D procedures, administer appropriate intravenous prophylactic antibiotics within 1 hour before incision, or 2 hours for vancomycin (Grade A.) [1]
  • For class C and D procedures, reserve vancomycin for patients colonized with MRSA or considered at high risk for MRSA (Grade A.) [1]
  • For all listed classes, do not routinely remove hair. If removal is needed, use electric clippers immediately before surgery. Both recommendations are Grade A. [1]
  • Before implantable-device surgery in class C or D, identify and optimize risk factors such as tobacco use and diabetes (Grade B.) [1]
  • For class D implantable-device surgery, the ideal perioperative blood-glucose level is ≤150 mg/dL (Grade B.) [1]
  • For class C and D pain-device implantation, obtain nasal testing for MRSA and MSSA and decolonize patients who are colonized (Grade B.) [1]

Catheter duration and joint injections

  • Where possible, avoid externalized neuraxial catheters beyond 2 weeks in class C procedures to reduce meningitis risk (Grade B.) [1]
  • For class B and C regional nerve-block catheters, continuation beyond 4–5 postprocedure days requires an individualized benefit–risk decision and careful infection monitoring (Grade C.) [1]
  • For class A procedures, avoid intra-articular steroid injection within 1 month of planned replacement of that joint, and do not offer these injections after total knee arthroplasty or total hip replacement. Both recommendations are Grade D. [1]

Aseptic technique and procedural care

  • Across all listed classes, use sterile gloves and prefer chlorhexidine-based skin antisepsis, including for neuraxial procedures. Disinfect medication-vial rubber septa with alcohol before piercing. These are Grade B recommendations. [1]
  • Use a surgical cap and eye protection for class B, C and D procedures, and a sterile surgical gown for class C and D. These are Grade B recommendations. [1]
  • For class C intradiscal procedures, both a styletted needle and a double-needle technique are recommended at Grade B. [1]
  • For class C and D procedures, avoid unnecessary delays that prolong the procedure (Grade A.) [1]
  • For class D surgery, routine vancomycin powder in the wound is not recommended; evidence is insufficient or conflicting to determine the balance of benefit and harm. [1]

Recognize and investigate infection

  • If surgical-site infection is suspected after any listed procedure class, obtain a differential blood count, ESR and CRP and follow trends. For suspected meningitis after class B, C or D procedures, cerebrospinal-fluid analysis is the diagnostic method of choice when not contraindicated. Both are Grade A recommendations. [1]
  • For class B and C indwelling catheters, discontinue catheter use at the earliest signs of infection and institute appropriate early medical or surgical management (Grade A.) [1]
  • For all listed classes, guide antibiotic treatment by preoperative or intraoperative culture results when possible (Grade A.) [1]
  • In class C and D device-related infection, consider complete system explantation, particularly for deep subfascial or complicated infection (Grade A.) [1]

Treatment planning and follow-up

  • Across all listed classes, involve an infectious-disease specialist in the antibiotic plan for complicated or neuraxial infection, systemic or multidrug-resistant infection, relevant drug allergies, chronic kidney disease, or comorbidities increasing resistant-infection risk (Grade B.) [1]
  • For superficial infection after any listed class, a trial of oral antibiotics may be considered with close monitoring, typically for 7–10 days and covering staphylococcal and streptococcal species (Grade C.) [1]
  • Educate patients and families about incision care, infection symptoms and the importance of reporting them for all listed procedure classes (Grade C.) [1]
  • For class D procedures, maintain a bio-occlusive dressing for at least 24 hours (Grade B.) [1]

Limitations and use

  • This is a selected summary of three society recommendation sheets, not the full corrected infection-control guideline.
  • Confirm the specific procedure class in the original classification table before applying a class-restricted recommendation; broad procedure headings alone do not determine classification.
  • Not all environmental, closure, antimicrobial-prophylaxis-duration and decolonization-repeat recommendations are reproduced.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Infection control for regional anaesthesia and pain medicine

    Selected recommendation material consulted

Consensus practice guideline

Publication details

Issuing organisation
ASRA Pain Medicine
First published
20 January 2025
Resource type
Consensus practice guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Preparation and prophylaxis
  • Catheter duration and joint injections
  • Aseptic technique and procedural care
  • Recognize and investigate infection
  • Treatment planning and follow-up
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House